Surgery Partners buyers raise takeover price to $25 a share

The buyers taking Surgery Partners private have raised their offer to $25.00 a share from $23.50, under an amendment to the merger agreement dated November 8, 2026 and filed with the SEC on Monday.

Why it matters: The increase lifts the value of the $5.7 billion take-private of one of the largest US ambulatory surgery networks, and the amendment adds monthly cash payments to shareholders if the deal has not closed by March 1, 2027.

Data as of Surgery Partners 8-K filed November 9, 2026 (accession 0001104659-26-124236), read in full in this run; every term comes from the filing itself. The original $23.50 price is from the October 23, 2026 merger agreement, covered by this site on October 25. Developing item.

The consortium taking Surgery Partners private has raised its price. Amendment No. 1 to the merger agreement, dated November 8, 2026 and filed with the SEC on Monday, increases the per share consideration to $25.00, from the $23.50 agreed on October 23, and also raises the company termination fee and provides for reimbursement of certain buyer expenses.

The amendment adds a timing protection for shareholders: if the closing has not occurred by March 1, 2027, holders of common stock receive monthly cash payments, with corresponding payments in respect of company awards, until the deal completes. The buyer group is led by Spyglass Topco, an affiliate of Bon Secours Mercy Health, whose HealthSpan Partners agreed in October to take the ambulatory surgery operator private in a deal then valued at about $5.7 billion including debt.

Surgery Partners buyers raise takeover price to $25 a share

Sources